| Tradename | Applicant | Generic Name | Patent No. | Patent Expiration | |||||
|---|---|---|---|---|---|---|---|---|---|
| LOTRONEX | Prometheus Labs | alosetron hydrochloride | 5,360,800 | Jan 13, 2013 | |||||
| IRESSA | Astrazeneca | gefitinib | 5,457,105 | Jan 19, 2013 | |||||
| IRESSA | Astrazeneca | gefitinib | 5,616,582 | Jan 19, 2013 | |||||
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.
| |||||||||
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration | |||||
|---|---|---|---|---|---|---|---|---|---|
| ACCOLATE | Astrazeneca | zafirlukast | 5,482,963 | Jan 9, 2013 | |||||
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.
| |||||||||
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration | |||||
|---|---|---|---|---|---|---|---|---|---|
| EPIVIR-HBV | Glaxosmithkline | lamivudine | RE39155*PED | Jan 2, 2013 | |||||
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.
| |||||||||
